The Ensign Group, Inc. (NASDAQ:ENSG) Receives Consensus Rating of "Moderate Buy" from Brokerages

Key Points

• Analyst consensus: Seven analysts rate The Ensign Group a "Moderate Buy" (five buy, two hold) with an average 12‑month target of $204.60 and individual targets ranging up to $230.00.
• Quarterly results and guidance: The company reported EPS of $1.82 (beat by $0.07) and revenue of $1.36B (slightly below estimates), with revenue up 20.2% YoY and FY2026 guidance of $7.410–$7.610 EPS.
• Dividends and insider activity: Ensign declared a quarterly dividend of $0.065 ($0.26 annualized, ~0.1% yield) while insiders sold 17,073 shares (~$3.35M) over the last three months and institutional ownership stands at 96.12%.

Shares of The Ensign Group, Inc. (NASDAQ:ENSG - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the seven analysts that are covering the company, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average twelve-month target price among analysts that have covered the stock in the last year is $204.60.

Several research firms have recently weighed in on ENSG. Weiss Ratings reiterated a "buy (b)" rating on shares of The Ensign Group in a research report on Thursday, January 22nd. UBS Group set a $230.00 price target on shares of The Ensign Group and gave the company a "buy" rating in a research note on Friday, February 6th. Truist Financial set a $215.00 price target on shares of The Ensign Group and gave the company a "hold" rating in a research note on Friday, February 6th. Zacks Research downgraded shares of The Ensign Group from a "strong-buy" rating to a "hold" rating in a research note on Monday, April 6th. Finally, Royal Bank Of Canada reaffirmed an "outperform" rating and set a $222.00 price target (up from $206.00) on shares of The Ensign Group in a research note on Monday, February 9th.

The Ensign Group Price Performance

Shares of NASDAQ:ENSG opened at $199.02 on Monday. The company has a current ratio of 1.42, a quick ratio of 1.42 and a debt-to-equity ratio of 0.06. The Ensign Group has a 12 month low of $118.73 and a 12 month high of $218.00. The company has a 50-day moving average price of $204.35 and a 200 day moving average price of $187.64. The company has a market cap of $11.53 billion, a price-to-earnings ratio of 34.08, a PEG ratio of 1.95 and a beta of 0.81.

The Ensign Group (NASDAQ:ENSG - Get Free Report) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $1.82 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.75 by $0.07. The company had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.37 billion. The Ensign Group had a return on equity of 16.76% and a net margin of 6.80%.The Ensign Group's revenue was up 20.2% on a year-over-year basis. During the same period last year, the company earned $1.49 earnings per share. The Ensign Group has set its FY 2026 guidance at 7.410-7.610 EPS. As a group, equities research analysts predict that The Ensign Group will post 5.59 earnings per share for the current year.

The Ensign Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, April 30th. Stockholders of record on Tuesday, March 31st will be paid a dividend of $0.065 per share. This represents a $0.26 annualized dividend and a dividend yield of 0.1%. The ex-dividend date of this dividend is Tuesday, March 31st. The Ensign Group's payout ratio is currently 4.45%.

Insider Transactions at The Ensign Group

In related news, Director John O. Agwunobi sold 146 shares of The Ensign Group stock in a transaction dated Wednesday, January 21st. The stock was sold at an average price of $178.31, for a total value of $26,033.26. Following the completion of the sale, the director directly owned 9,087 shares in the company, valued at $1,620,302.97. The trade was a 1.58% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, VP Beverly B. Wittekind sold 500 shares of The Ensign Group stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $210.23, for a total value of $105,115.00. Following the completion of the sale, the vice president owned 32,779 shares of the company's stock, valued at $6,891,129.17. The trade was a 1.50% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 17,073 shares of company stock valued at $3,349,532 over the last three months. 3.90% of the stock is currently owned by corporate insiders.

Institutional Trading of The Ensign Group

Several institutional investors and hedge funds have recently made changes to their positions in the company. Private Trust Co. NA raised its stake in The Ensign Group by 156.5% in the fourth quarter. Private Trust Co. NA now owns 159 shares of the company's stock worth $28,000 after buying an additional 97 shares in the last quarter. Monetary Solutions Ltd bought a new position in The Ensign Group in the fourth quarter worth approximately $30,000. Northwestern Mutual Wealth Management Co. raised its stake in The Ensign Group by 55.0% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 172 shares of the company's stock worth $30,000 after buying an additional 61 shares in the last quarter. Bayban bought a new position in The Ensign Group in the fourth quarter worth approximately $31,000. Finally, Harbor Investment Advisory LLC raised its stake in The Ensign Group by 125.6% in the fourth quarter. Harbor Investment Advisory LLC now owns 194 shares of the company's stock worth $34,000 after buying an additional 108 shares in the last quarter. 96.12% of the stock is currently owned by institutional investors.

About The Ensign Group

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company's model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.